Literature DB >> 7666088

Lymph node staging standards in gastric cancer.

A M Bunt1, P C Hogendoorn, C J van de Velde, J A Bruijn, J Hermans.   

Abstract

PURPOSE: In tumor-node-metastasis (TNM) staging, no recommendations are provided on the number of lymph nodes to examine per N level. We investigated the relationship between number of nodes examined and probability of detecting metastases, and ultimately staging accuracy. PATIENTS AND METHODS: Data from 473 curatively resected gastric cancer patients, from a randomized trial that compared the Western resection with limited and the Japanese resection with extended lymphadenectomy, were used.
RESULTS: Yields varied between zero to 67 in N1 and zero to 43 in N2. Yields correlated significantly with classification; the more nodes examined, the more likely the classification was N+. Calculating the probability of detecting metastases using either a likelihood-ratio estimate or an exponential model, this probability increased steeply in the lower range and more gradually in the higher range yield.
CONCLUSION: To standardize treatment results, we emphasize histologic examination of a fixed number of nodes per anatomically defined N level (20 in N1 and 15 in N2), corresponding with a probability to detect metastases of 60% to 65% and 40% to 45%, respectively. These yields are feasible in all resection specimens, while the extra increase in the chance of detecting metastases by examining more nodes does not compensate the effort to increase yields further. Thus, standardization of histologic TNM staging can improve and render comparison of surgical and adjuvant treatment modalities feasible.

Entities:  

Mesh:

Year:  1995        PMID: 7666088     DOI: 10.1200/JCO.1995.13.9.2309

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  5 in total

1.  Adopting postoperative chemoradiotherapy in resected gastric cancer.

Authors:  John S Macdonald
Journal:  Gastrointest Cancer Res       Date:  2009-11

2.  Prognostic Analysis of Gastric Signet Ring Cell Carcinoma and Hepatoid Adenocarcinoma of the Stomach: A Propensity Score-Matched Study.

Authors:  Yu Yang; Yuxuan Li; Xiaohui Du
Journal:  Front Oncol       Date:  2021-08-11       Impact factor: 6.244

3.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study.

Authors:  J R Siewert; K Böttcher; H J Stein; J D Roder
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

Review 4.  Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward.

Authors:  Konstantinos Papadimitriou; Georgios Antoniou; Christian Rolfo; Antonio Russo; Giuseppe Bronte; Vassilios Vassiliou; Demetris Papamichael; Marc Peeters; Panteleimon Kountourakis
Journal:  Gastroenterol Res Pract       Date:  2015-05-26       Impact factor: 2.260

5.  Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.

Authors:  Shiela S Macalindong; Kwang Hee Kim; Byung-Ho Nam; Keun Won Ryu; Norihito Kubo; Ja Yeon Kim; Bang Wool Eom; Hong Man Yoon; Myeong-Cherl Kook; Il Ju Choi; Young Woo Kim
Journal:  BMC Cancer       Date:  2018-01-12       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.